# A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis

> **NCT00244647** · PHASE1 · TERMINATED · sponsor: **Sarepta Therapeutics, Inc.** · enrollment: 40 (—)

## Conditions studied

- Coronary Artery Disease
- Coronary Stent Restenosis

## Interventions

- **DRUG:** RESTEN-MP

## Key facts

- **NCT ID:** NCT00244647
- **Lead sponsor:** Sarepta Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (—)
- **Last updated:** 2008-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00244647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00244647, "A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00244647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*